Cartesian Therapeutics, Inc.
RNAC
$6.65
-$0.06-0.89%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 143.38M | 160.32M | 180.43M | 212.61M | 219.20M |
| Total Receivables | 722.00K | 354.00K | 1.77M | 872.00K | 5.81M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.15M | 2.72M | 2.92M | 3.14M | 4.13M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 147.26M | 163.40M | 185.12M | 216.63M | 229.14M |
|
|
|||||
| Total Current Assets | 147.26M | 163.40M | 185.12M | 216.63M | 229.14M |
| Net Property, Plant & Equipment | 17.37M | 17.45M | 15.53M | 15.45M | 23.75M |
| Long-term Investments | 48.16M | 48.16M | 48.16M | 48.16M | 48.16M |
| Goodwill | 48.16M | 48.16M | 48.16M | 48.16M | 48.16M |
| Total Other Intangibles | 150.60M | 150.60M | 150.60M | 150.60M | 150.60M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.29M | 7.29M | 7.72M | 2.19M | 1.67M |
| Total Assets | 372.68M | 388.89M | 409.13M | 435.02M | 455.32M |
|
|
|||||
| Total Accounts Payable | 2.23M | 454.00K | 2.10M | 288.00K | 517.00K |
| Total Accrued Expenses | 7.60M | 7.32M | 8.67M | 11.29M | 9.02M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.88M | 3.79M | 3.70M | 2.85M | 2.77M |
| Total Finance Division Other Current Liabilities | 107.00K | 688.00K | 531.00K | 8.54M | 9.09M |
| Total Other Current Liabilities | 107.00K | 688.00K | 531.00K | 8.54M | 9.09M |
| Total Current Liabilities | 13.80M | 12.26M | 15.00M | 22.98M | 21.41M |
|
|
|||||
| Total Current Liabilities | 13.80M | 12.26M | 15.00M | 22.98M | 21.41M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 8.73M | 9.56M | 10.36M | 11.13M | 11.88M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 385.99M | 369.61M | 405.56M | 407.72M | 421.28M |
| Total Liabilities | 408.52M | 391.42M | 430.92M | 441.83M | 454.56M |
|
|
|||||
| Common Stock & APIC | 698.54M | 695.95M | 692.58M | 689.89M | 687.18M |
| Retained Earnings | -729.80M | -693.90M | -709.78M | -692.07M | -681.82M |
| Treasury Stock & Other | -4.59M | -4.58M | -4.59M | -4.62M | -4.61M |
| Total Common Equity | -35.84M | -2.53M | -21.79M | -6.80M | 752.00K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -35.84M | -2.53M | -21.79M | -6.80M | 752.00K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -35.84M | -2.53M | -21.79M | -6.80M | 752.00K |
|
|
|||||